CME/CE
This activity is jointly provided by Postgraduate Institute for Medicine and DKBmed, LLC. This activity is supported by an independent educational grant from Genentech, a member of the Roche Group.
Credit Available
Physicians — maximum of 0.5 AMA PRA Category 1 Credit(s)™
Nurses — 0.5 Contact Hours
Target Audience
This activity is intended for clinicians treating patients in underserved populations.
Educational Objectives
After completing this activity, the participant should be better able to:
- Identify risk factors (eg, social determinants of health, comorbidities) that increase risk for severe COVID-19
- Describe current management strategies and identify potential treatments for mild and moderate COVID-19
- Describe current management strategies and identify approved and in-development treatments for patients with COVID-19 requiring hospitalization
Faculty
Kirsten Austad, MD, MPH
Assistant Professor
Departments of Family Medicine
Boston University School of Medicine
Medical Director, HealthNet Inpatient Unit
James Hudspeth, MD, FACP
Assistant Professor
Section of General Internal Medicine
Inpatient Lead for COVID-19 Response
Department of Medicine
Boston University School of Medicine
Angela McLaughlin, MD, MPHTM
Division of Infectious Diseases
Department of Medicine
Boston Medical Center
Glory Ruiz, MD
Director, Public Health Programs
Section of Infectious Diseases
Boston Medical Center
Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies. All identified conflicts of interest (COI) are thoroughly vetted and mitigated according to PIM policy. PIM is committed to providing its learners with high quality accredited continuing education activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.
The faculty reported the following relevant financial relationships with ineligible entities related to the educational content of this CE activity:
Glory Ruiz, MD
- Research Grant: Gilead Sciences, Inc.
Kirsten Austad, MD, MPH
James Hudspeth, MD, FACP
Angela McLaughlin, MD, MPHTM
The PIM planners and others have nothing to disclose. The DKBmed planners and others have nothing to disclose.
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and DKBMed. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation
Physician Continuing Medical Education
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Continuing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 0.5 contact hours.
Method of Participation and Request for Credit
There are no fees for participating and receiving CME credit for this enduring activity. To receive CME credit participants must:
- Read the CME/CE information and faculty disclosures.
- Participate in the online activity.
- Submit the evaluation form.
Certificates will be available for print or download.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.